The Indian active pharmaceutical ingredient (API) maker told Bombay Stock Exchange (BSE) that during a meeting held on November 22, 2010, its board of directors approved a proposal to acquire the Italian firm through its wholly owned subsidiary to be set up in Mauritius.
In the meeting the board also approved formation of a subsidiary Company in the United Arab Emirates (UAE) which Camlin hopes will further establish its business through Middle Eastern regions.